Loco-regional B7H3 IL-7Ra CAR T Cell therapy(Chulalongkorn University)

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameLoco-regional B7H3 IL-7Ra CAR T Cell therapy(Chulalongkorn University)
Drug Alias NameB7H3 With IL-7 Receptor Alpha Signaling Chimeric Antigen Receptor T Cell therapy(Chulalongkorn University)B7H3 specific CAR T cell with IL-7Ra signaling domain (Chulalongkorn University)CMD03CMD-03
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vectorCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionT lymphocyte replacementsCD276 antigen modulatorsInterleukin-7 receptor subunit alpha modulators
TargetsCD276 antigenInterleukin-7 receptor subunit alpha
Therapy Area/IndicationsSolid tumoursBrain NeoplasmsDiffuse Intrinsic Pontine Glioma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChulalongkorn UniversityKing Chulalongkorn Memorial Hospital
China Registration ClassN/A

Develop Information

Active CompaniesKing Chulalongkorn Memorial HospitalChulalongkorn University
Inactive CompaniesN/A
Active IndicationsSolid tumoursBrain NeoplasmsDiffuse Intrinsic Pontine Glioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A